Gene Therapy Uptake: The Elephant in the Room

Available On Demand

How can companies maximize their potential when launching a gene therapy product?

Gene therapy commercialization is in its infancy. Limited commercial precedent creates significant difficulty in modeling gene therapy revenue and uptake. The single administration nature of the products also presents a unique challenge for companies as the eligible patient population decreases over time.

In this webinar, Trinity Life Sciences’ cell and gene therapy experts evaluate the factors that are unique to forecasting gene therapy markets and share what companies need to know to maximize their revenue potential and successfully navigate the elephant in the room.

Key Webinar Topics

• Key market drivers and product factors contributing to gene therapy opportunity
• Critical launch success factors, including patient identification, site selection and therapy acceptance
• Potential pricing strategies to consider

Featuring

Complete the form below to view the on-demand webinar.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.